Hepatoblastoma - 20 Studies Found

Completed : A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
:
  • Medulloblastoma
  • Rhabdomyosarcoma
  • Neuroblastoma
  • : 2010-05-12
    : Drug: LDE225 LDE225/sonidegib capsules were supplied to the Investigators at dose strengths of 50 mg, 10
Not yet recruiting : G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
:
  • Acute Myeloid Leukemia
  • Acute Lymphoid Leukemia
  • Lymphoma : 2016-10-08
    :
    • Biological: GM-CSF Granulocyte
Active, not recruiting : Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
:
  • Hepatoblastoma
  • Previously Treated Childhood Rhabdomyosarcoma : 2010-06-30
    :
    • Drug: Alisertib Given orally
Recruiting : Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
:
  • Ewing's Family Tumors
  • Renal Tumors
  • H
    : 2012-01-04
    :
    • Drug: Ifosfamide

Withdrawn : Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors
:
  • Childhood Hepatoblastoma
  • Previously Treated Childhood Rhabdomyo
    : 2013-12-10
    :
    • Drug: imetelstat sodium Given

Recruiting : Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
:
  • Retinoblastoma
  • Clear Cell Sarcoma
  • Renal Cell Carcinoma : 2015-02-24
    :
    • Drug: Simvastatin The starting
Active, not recruiting : Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
:
  • Ewing's Sarcoma
  • Osteosarcoma
  • Astrocytoma
  • Adult Rhabdomyosarcoma
  • Adult Synovial Sarcoma
  • Childhood : 2009-01-28
    :
    • Biological: cixutumumab Given

Recruiting : A Phase II Trial of Reduced Intensity Conditioning and Haploidentical BMT for High-risk Solid Tumors
: Refractory and/or Relapsed Metastatic Solid Tumors
: 2013-03-01
:
  • Drug: Cyclophosphamide prepara